0001415889-23-004679.txt : 20230310 0001415889-23-004679.hdr.sgml : 20230310 20230310170641 ACCESSION NUMBER: 0001415889-23-004679 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckbee Kevin K CENTRAL INDEX KEY: 0001968528 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 23724612 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 3 1 form3-03102023_100331.xml X0206 3 2023-03-01 0 0001551152 AbbVie Inc. ABBV 0001968528 Buckbee Kevin K 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 false true false false SVP, Controller Common Stock, $0.01 par value 7163 D Option (Right to buy) 93.50 2021-02-20 2030-02-19 Common Stock 13911 D Option (Right to buy) 105.92 2022-02-18 2031-02-17 Common Stock 9316 D Option (Right to buy) 144.54 2023-02-17 2032-02-16 Common Stock 7005 D Option (Right to buy) 149.62 2024-02-16 2033-02-15 Common Stock 6076 D Includes 6,918 restricted stock units granted under the AbbVie Amended and Restated 2013 Incentive Stock Program. These restricted stock units vest in full on February 17, 2025, and include the right to have stock withheld for tax purposes. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 4,637 shares on 2/20/2021, as to 4,637 shares on 2/20/2022, and as to 4,637 shares on 2/20/2023. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 3,106 shares on 2/18/2022, as to 3,105 shares on 2/18/2023, and will become exercisable as to 3,105 shares on 2/18/2024. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 2,335 shares on 2/17/2023, as to 2,335 shares on 2/17/2024 and as to 2,335 shares on 2/17/2025. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 2,026 shares on February 16, 2024, as to 2,025 shares on February 16, 2025, and as to 2,025 shares on February 16, 2026. Steven L. Scrogham, attorney-in-fact for Kevin K. Buckbee 2023-03-10 EX-24 2 ex24-03102023_100331.htm

POWER OF ATTORNEY

The undersigned constitutes and appoints PERRY C. SIATIS, JENNIFER M. LAGUNAS, EMILY A. WEITH and STEVEN L. SCROGHAM, and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings, and any amendments or successors to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact.

Date: February 7, 2023

/s/ Kevin Buckbee
Signature of Reporting Person

Kevin K. Buckbee

Name

AbbVie Inc.

1 N. Waukegan Road

North Chicago, IL 60064